Compare Globus Medical Inc. Class A Common Stock (GMED) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Paychex, Inc. — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Paychex, Inc. trades at $109.38 (market cap $37.82B). The key difference: Paychex, Inc. is far larger — about 3.7× Globus Medical Inc. Class A Common Stock's market cap, and Paychex, Inc. pays a 4.48% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Paychex, Inc. for 56 Days on average.
| GMED | PAYX | |
|---|---|---|
Market Cap | $10.25B | $37.82B |
Volume | 1,108,124 | 2,018,238 |
Sector | Health | Industrials |
52-Week High | $96.82 | $127.54 |
52-Week Low | $58.33 | $85.57 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $9.76B | $41.51B |
Dividend Yield | — | 4.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Paychex (PAYX) trades at $108.37, up 3.56% today, with mixed technical signals showing bullish overall momentum but bearish moving averages. The company maintains strong fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.34 beating $1.32 estimates, and robust profitability metrics including 27.35% net income margin and 47.06% ROE. Recent news highlights dividend safety concerns despite the company's 5-star rating on Newsweek's America's Greatest Companies 2026 list.
Outlook remains cautiously optimistic with analyst consensus target of $111 suggesting modest upside, though high valuation multiples (P/E 21.08, P/S 5.77) and competitive pressures in payroll services present risks. The stock offers income potential with recent $1.19 dividend, but investors should monitor PEO segment performance and labor market trends affecting small business clients.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
